Cellular therapies are on the cusp of approval in the blood cancer space — but there’s work yet to be done in reengineering T cells to target solid tumor cancers.
Dr. Kristin Anderson of Fred Hutchinson Cancer Center has some intriguing preclinical work in developing T cells that know how to kill ovarian and pancreatic cancers.
About the Author Reprints
